BACKGROUND Hemolytic uremic syndrome (HUS) is a rare condition that occasionally is
reported in cancer patients. Recently it has been observed that gemcitabine rarely may be …

Context Hemolytic uremic syndrome is a rare condition compromising the clinical triad of
acute renal failure, microangiopathic hemolytic anemia, and thrombocytopenia. Hemolytic …

A variety of renal diseases and electrolyte disorders may be associated with various
malignancies or with treatment of malignancy with chemotherapeutic drugs or radiation …

In adults, the haemolytic-uraemic syndrome (HUS) is associated with probable causative
factors in the minority of all cases. Cytotoxic drugs are one of these potential causative …

Nephrotoxicity is an inherent adverse effect of certain anticancer drugs. Antineoplastic drugs
have a narrow therapeutic index and the amount of drug necessary to produce a significant …

Lung transplantation is now a viable therapeutic option in the care of patients with advanced
pulmonary parenchymal or pulmonary vascular disease. Lung transplantation, however …

Introduction Oxaliplatin is a third-generation platinum compound with proven antitumor
activity in the treatment of colorectal cancer. The occurrence of life-threating hemolitic uremic …

Background: In obstetrical service it is frequent to find women with acute renal failure during
second trimester of pregnancy. Main causes are related to hypertensive alterations …

Gemcitabine is frequently used for the treatment of a number of different cancer types.
Gemcitabine‑related thrombotic microangiopathy (TMA) has rarely been described, but it is a …

Se hace una revisión de los aspectos actuales en relación con la epidemiología y patogenia
del síndrome hermolítico urémico. El síndrome hemolítico urémico es el resultado de la …